Samuel Benarroch

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?

Yachar Dawudi, Yachar Dawudi, Samuel Benarroch, Samuel Benarroch, H. L. Helfer, H. L. Helfer, David M. Smadja, David M. Smadja, Isabelle Mahé, Isabelle Mahé (2024). Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?. , 9(1), DOI: https://doi.org/10.1016/j.rpth.2024.102667.